Close Menu

People in the News

Mar 14, 2019

Michael Ball

Contextual Genomics has appointed Michael Ball as the firm's CEO. He previously served as global VP of commercial, informatics, at Illumina. Prior to Illumina, Ball acted as CEO of GenoLogics Life Sciences Software. He is currently a director of the Canary Foundation, a non-profit focused on early cancer detection.

Mar 13, 2019

Stephen Brecher

First Light Diagnostics has added Stephen Brecher to its clinical advisory board. He has been a practicing clinical microbiologist for 50 years and is the director of microbiology at the VA Boston HealthCare System, as well as an associate professor of pathology and laboratory medicine at the Boston University School of Medicine. He also is on the editorial board of the Journal of Clinical Microbiology.

Mar 12, 2019

Phi Vu

Phi Vu has joined AdvaMedDx as its vice president. Vu was the director for health policy at the Biotechnology Innovation Organization. Previous to that he was in the US Department of Defense's Chemical and Biological Defense Program. AdvaMedDx is a division of the Advanced Medical Technology Association focusing on the value that diagnostics to healthcare.

Mar 12, 2019

Norman Sharpless

The US Health and Human Services Secretary Alex Azar has appointed Norman Sharpless as acting commissioner of the US Food and Drug Administration. Sharpless, currently the director of the National Cancer Institute, will take over for current FDA Commissioner Scott Gottlieb who announced on March 5 that he will resign from the post in one month. Before his position at the NCI, Sharpless directed the University of North Carolina's Lineberger Comprehensive Cancer Center, authored more than 100 research papers, and treated leukemia patients.

Mar 12, 2019

Patricia Rivera

Bioaffinity Technologies has formed a scientific and medical advisory board and named Patricia Rivera as the chairperson. Rivera is a professor of pulmonary diseases and critical care medicine at the University of North Carolina School of Medicine. She is also director of the UNC Lung Cancer Screening Clinic.

Mar 12, 2019

David Hoak, Bruce Beckwith, Eric Glassy, John Spinosa

Gestalt Diagnostics has created an advisory board, which is being led by the company's medical director David Hoak. Other members include Bruce Beckwith, chairman of pathology of North Shore Medical Center in Salem, Massachusetts; Eric Glassy, director of pathology at Providence Little Company of Mary Medical Center in San Pedro, California; and John Spinosa, chief medical officer at the San Diego Blood Bank. 


Mar 12, 2019

Rick Wenstrup

Rick Wenstrup has stepped down as chief medical officer at Oxford Immunotec, the company disclosed during an earnings call this week. Prior to joining Oxford Immunotec, Wenstrup was executive vice president and CMO for Myriad Genetics. He also previously served as CMO for Myriad Genetic Laboratories.

Mar 04, 2019

Robert Klug

Quest Diagnostics reported this week that Robert Klug, the company's vice president, controller, and chief accounting officer, will be leaving Quest on May 1. He will remain at his current position until then or until a successor is named, whichever occurs first, Quest said in a document filed with the US Securities and Exchange Commission. It did not give a reason for his departure. 

Mar 04, 2019

Kathleen Sebelius

Exact Sciences has appointed Kathleen Sebelius to serve as a director on its board. She will sit on the firm's corporate governance and nominating committee and on its innovation, technology and pipeline committee. Sebelius currently serves as CEO of Sebelius Resources, a strategic consulting firm that advises private companies, non-profit organizations, and financial investors. From April 2009 through June 2014, she served as the Health and Human Services Secretary for President Barack Obama. She also served as Governor of Kansas from 2003 to 2009, and her previous elected offices include two terms as the Kansas insurance commissioner and four terms in the Kansas legislature.

Sebelius currently sits on the boards of biopharmaceutical companies Dermira and Myovant Sciences, as well as the Kaiser Family Foundation. She also co-chairs the Aspen Institute Health Strategy Group and serves on advisory boards for the Dole Institute of Politics, Solera Health, Out Leadership, the Estée Lauder Foundation, and the University of Kansas College of Liberal Arts and Sciences.

Feb 27, 2019

Todd Wood

DermTech has appointed Todd Wood as the firm's chief commercial officer. Wood brings 25 years of pharmaceutical and medical device commercialization experience to the firm. He has previously launch multiple market products, including Juvéderm, Limigan, and Rhofade.

Feb 27, 2019

Jan Lundberg

Jan Lundberg has joined Metabolon's board of directors. He was most recently the president of Lilly Research Labs and head of R&D at Eli Lilly, and has held management positions at AstraZeneca and the Karolinska Institute. Lundberg is also the cofounder of Aerocrine and currently serves on the boards of Ardelyx, Betagenon Image Analysis Group, and TB Alliance. He will be an independent director at Metabolon. 

Feb 26, 2019

Jack Crowley, Kavita Patel, Garry Nicholson

Personal Genome Diagnostics has appointed Jack Crowley as its chief financial officer. Crowley most recently served as CFO at Lantheus Medical Imaging, where he led a transition from a private equity-backed to a publicly-traded global life sciences company. Prior to serving as CFO, Crowley also served as Lantheus' chief accounting officer, VP of finance, and global corporate controller. He also served as director of finance and assistant corporate controller at Biogen and director of accounting at Thermo Fischer Scientific. A Certified Public Accountant, he holds an MBA from the University of Massachusetts and a BS in Business Administration from Westfield State University.

PGDx has also appointed Kavita Patel and Garry Nicholson to its board of directors. Patel has served in the Obama Administration as director of policy for the Office of Intergovernmental Affairs and Public Engagement in the White House. Prior to the White House, she served as deputy staff director on health on the late Senator Edward Kennedy's staff. She also serves on the board of directors at Dignity Health and SSM Health Care. 

Nicholson currently serves as director at Five Prime Therapeutics, G1 Therapeutics, Tmunity Therapetics Inc, and SQZ Biotechnology. He previously served as President and CEO of XTuit Pharmaceuticals, as well as a member of the firm's board of directors. Prior to that, he served as president of Pfizer Oncology. He has also served on the Pfizer Foundation's board of directors and was a member of the firm's Portfolio, Strategy, and Investment Committee. In addition, Nicholson previously held leadership positions in the oncology division of Eli Lily. 

Feb 25, 2019

Don Elsey

OpGen has appointed Don Elsey to its board of directors and as the chairman of its audit committee. Elsey previously served as chief financial officer of Senseonics from 2015 to 2019. Prior to Senseonics, Elsey served as CFO of Regado Biosciences. He as also served as CFO of LifeCell and Emergent Biosolutions. In addition, Elsey has held senior financial positions at BioVeris, Igen, and PE (Applera). 

Feb 22, 2019

Jenne Britell, Jeffrey Leiden

Jenne Britell and Jeffrey Leiden have told Quest Diagnostics that they will not seek reelection to the company's board at its annual shareholders' meeting to be held on May 14, Quest said in a document filed with the US Securities and Exchange Commission. They informed the company on Feb. 18. Quest previously announced that Denise Morrison had been elected to the board, increasing its size to 11 directors from 10. 

Feb 21, 2019

Ciarán Kelly, Mark Wilcox, Dale Gerding

First Light Diagnostics has named Ciarán Kelly, Mark Wilcox, and Dale Gerding to its clinical advisory board. Kelly currently serves as the chief of Herman Blumgart Internal Medicine, director of gastroenterology training, and medical director of the Celiac Center at Beth Israel Deaconess Medical Center. Wilcox currently serves as the director of pathology at the Leeds Teaching Hospitals. Gerding previously served as president and chair of the Society for Healthcare Epidemiology of America.

Feb 19, 2019

Anthony Schmidt

Circulogene has named Anthony Schmidt as the firm's medical director. He will lead the lab's precision medicine initiatives and educate the medical community about the firm's technologies. Schmidt was most recently pathology chair and lab medical director for the Mississippi Baptist Healthcare System.

Feb 19, 2019

Leo Grady

Paige.AI has named Leo Grady as its CEO and a board member. The New York-based startup was launched last year and leverages technology developed by its Cofounder and CSO Thomas Fuchs to digitize pathology slides from Memorial Sloan Kettering Cancer Center. The company has a licensing agreement with MSK and said it is on its way to digitizing 5 million pathology slides from the center. Grady was previously senior vice president of engineering for HeartFlow. Prior to that, he was at Siemens where he served in a variety of scientific and leadership positions. 

Feb 19, 2019

Gabrielle Wolfson, Denise Morrison

Gabrielle Wolfson has been appointed Quest Diagnostics' senior vice president and chief information and digital officer. She joins the company fron Xerox where she had been CIO since 2016. Before that, she was CIO at Wyndham Hotels and Resorts and was CIO at Integra Life Sciences and Par Pharmaceutical. 

Quest also announced Denise Morrison has been elected to its board, effective Feb. 18. Morrison was president and CEO of Campbell Soup Company from 2011 to 2018. 

Feb 12, 2019

Sharon Klugewicz

Chembio said in a filing with the US Securities and Exchange Commission that Sharon Klugewicz is resigning as its senior vice president and chief quality and regulatory officer on Feb. 22.

Feb 06, 2019

Peter Kaspar

First Light Diagnostics has appointed Peter Kaspar to its board of directors. Kaspar has been a member of bioMérieux's executive committee, where he was responsible for the firm's molecular diagnostics unit, global research and development, and later the microbiology unit. Kaspar previously held executive roles within several global organizations, including the Foundation for Innovative Diagnostics.

Feb 06, 2019

Patti Connolly, Paul Brenner

RenalytixAI has appointed Patti Connolly as its VP of clinical and scientific affairs. Connolly will lead the firm's recruitment efforts for the prospective clinical utility study for its KidneyIntelX assay, which the firm plans to begin in Q4 2019. Prior to RenalytixAI, Connolly served as clinical services director at Pearl Pathways.

RenalytixAI has also appointed and Paul Brenner to the firm's advisory board. Brenner currently serves as a computer science faculty member at the University of Notre Dame and associate director of Notre Dame's Center for Research Computing. Brenner also serves as a senior reserve advisor to the Air Force Cyber College Commandment.

Jan 29, 2019

Esther Abels

PathAI announced Esther Abels has been appointed its vice president of regulatory and clinical affairs and strategic business development. She will direct the company's development of medical devices and lead its regulatory strategy. Abels was most recently a senior direcgtor at Philips where she led efforts to gain US Food and Drug Administration approval for whole-slide imaging systems. 

Jan 29, 2019

Jean-Francois Yale

Diagnos has appointed Jean-Francois Yale to its board. Yale is an endocrinologist and is currently a professor of medicine at McGill University's department of medicine. He chaired the clinical and scientific section of the Canadian Diabetes Association from 1992-1994.

Jan 28, 2019

Robert Yates, Martin Madaus

Ortho Clinical Diagnostics announced that its board of directors has appointed Robert Yates as chairman and chief executive officer effective Feb. 12. Yates will succeed Martin Madaus, who is retiring after serving as chairman and CEO of Ortho since June 2014. 

Yates is currently Ortho's president and has served as a director on the company's board since June 2014. He was previously the chief operating officer and a member of Ortho's executive leadership team for more than four years.

Jan 25, 2019

John Steuart, Gail Marcus

John Steuart has resigned from Natera's board of directors. The board has also appointed Gail Marcus as chair of the audit committee. She joined Natera's board in March 2017 and currently serves as chair of the nominating and corporate governance committee.